|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 84 TWD | -0.24% |
|
-2.21% | +4.35% |
| 05-21 | Ch Biotech R&D Co., Ltd. Approves the Appointments of the 4th Remuneration Committee Members | CI |
| 05-21 | CH Biotech R&D Co., Ltd. Announces Audit Committee Changes | CI |
CH Biotech R&D Co., Ltd. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was TWD 1,287.71 million compared to TWD 671.52 million a year ago. Net income was TWD 603.44 million compared to TWD 248.12 million a year ago.
Basic earnings per share from continuing operations was TWD 6.22 compared to TWD 2.56 a year ago. Diluted earnings per share from continuing operations was TWD 6.11 compared to TWD 2.53 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +4.35% | 266M | |
| +11.29% | 36.97B | |
| -.--% | 11.74B | |
| +25.10% | 7.75B | |
| -10.19% | 7.05B | |
| +7.53% | 6.88B | |
| -9.96% | 5.59B | |
| -11.32% | 5.24B | |
| -2.86% | 5.14B | |
| +28.14% | 5.03B |
CH BIOTECH R&D CO., LTD. 
